MAP2K7 and neoplasm: In vitro, hsa-miR-9-3p has also been identified as a tumor-suppressor miRNA targeting β1 integrin in claudin-low TNBC cells, resulting in the sensitization of MDA-MB-231 cells to MEK inhibition [41].